JNJ-48816274

· Janssen-Cilag International NV

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-48816274, covering 2025-04-27 to 2025-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274 [Phase 1]